Validation of Dermatophot for the assessment of steroid induced skin atrophy - Validel

J.W. Goethe University Hospital0 个研究点目标入组 36 人开始时间: 2008年4月1日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Exclusion criteria
•Clinical conditions that according to investigator can interfere with the Dermatophot evaluation (e.g., generalized erythroderma such as the genetic condition Netherton’s syndrome, other skin conditions such as atopic dermatitis, psoriasis)
•History of malignancy of any organ system, treated or untreated, within the past 5 years whether or not there is evidence of local recurrence or metastases
•Systemic immunosuppression
•Clinical signs of infection in the treatment area (e.g. viral, bacterial, fungal or specific skin disorders)
•History of hypersensitivity to investigated substances to drugs with similar chemical structures and/or to any other ingredients of the formulation
•Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hCG test. Females of childbearing potential and not practicing a medically approved method of contraception during and up to at least 4 weeks after the end of treatment. ‘Medically approved’ contraception may include implants, injectables, combined oral contraceptives, IUDs, but also abstinence at the discretion of the investigator
•Use of other investigational drugs within 30 days of enrolment

发起方

J.W. Goethe University Hospital